MEDLINE Journals

    Effect of therapeutic INR on activated clotting times, heparin dosage, and bleeding risk during ablation of atrial fibrillation.

    Gautam S, John RM, Stevenson WG, et al. 
    J Cardiovasc Electrophysiol 2011 Mar; 22(3) :248-54.

    Ablation of atrial fibrillation (AF) with international normalized ratio (INR) ≥ 2.0 is safe and may reduce thromboembolic complications. Heparin is administered during the procedure, but the effect of elevated INR on heparin requirements and target activation clotting times (ACT) ≥ 350 seconds during ablation is unknown.To study the effect of INR on intraprocedural anticoagulation during ablation of AF.We retrospectively studied 427 consecutive patients over an 18-month period when we were transitioning to continuation of warfarin for AF ablation. Baseline INR, procedural ACT measurements, heparin doses and major complications were analyzed according to Group 1 with INR < 2.0 (n = 246) and Group 2 with INR ≥ 2.0 (n = 181).In Group 1, the mean INR was lower (1.3 ± 0.3 s vs 2.4 ± 0.3; P < 0.001), and the mean heparin dose was greater (106.82 ± 40.01 vs 77.03 ± 18.5 U/kg; P < 0.001). A single heparin bolus achieved ACT ≥ 350 seconds throughout the procedure in 51 patients (20.7%) in Group 1 compared to 108 patients (59.7%) in Group 2 (P < 0.01). Mean ACT values were higher in Group 2. Symptomatic pericardial effusions were similar (2.4% in Group 1 and 2.2% in Group 2). There were 3 thromboembolic cerebrovascular events in Group 1 and none in Group 2. Femoral hematomas occurred more frequently in Group 1 (8.1%) than in Group 2 (3.3%) (P = 0.007).AF ablation with INR ≥ 2.0 provides a consistent anticoagulant milieu during the procedure, with lower heparin requirements that are important to anticipate.

    Atrial Fibrillation
    Blood Coagulation
    Catheter Ablation
    Chi-Square Distribution
    Drug Administration Schedule
    Drug Monitoring
    International Normalized Ratio
    Middle Aged
    Predictive Value of Tests
    Regression Analysis
    Retrospective Studies
    Risk Assessment
    Risk Factors
    Time Factors
    Treatment Outcome


    Pub Type(s)
    Journal Article
    PubMed ID


    Content Manager
    Related Content

    Preprocedural therapeutic international normalized ratio influence on bleeding complications in atrial fibrillation ablation with continued anticoagulation with warfarin.

    Catheter ablation for atrial fibrillation on uninterrupted warfarin: can it be done without echo guidance?

    Catheter ablation for atrial fibrillation on uninterrupted warfarin: NEED it be done WITH echo guidance?

    Impact of international normalized ratio and activated clotting time on unfractionated heparin dosing during ablation of atrial fibrillation.

    Safety of ablation for atrial fibrillation with therapeutic INR: comparison with transition to low-molecular-weight heparin.

    Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation.

    Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users.

    Safety and convenience of continuous warfarin strategy during the periprocedural period in patients who underwent catheter ablation of atrial fibrillation.